European Commission DG SANTE and the European Medicines Agency (EMA) have signed a working arrangement with the Health Sciences Authority of Singapore (HSA), to facilitate collaboration and exchange of information on medicines and medical devices, thus supporting public health and access to safe and quality medical products.
The working arrangement was signed by Sandra Gallina (in picture), Director-General of DG SANTE, Emer Cooke, Executive Director of the EMA and Adj Prof (Dr.) Raymond Chua, Chief Executive Officer Health Sciences Authority of Singapore.The working arrangement aims to strengthen collaboration and information exchange between the signatories in a range of areas of mutual interest.
Key areas for cooperation include:
Information exchange on product safety, efficacy, quality, clinical‑trial authorisation, labelling and policy development
Observer and expert participation in each other’s scientific committees, multilateral procedures and cluster activities, to foster mutual learning and capacity‑building
Training and knowledge‑sharing programmes to enhance regulatory science expertise and promote best practice across both jurisdictions.
The new working arrangement applies immediately, will be reviewed periodically and may be extended or adapted by mutual agreement.






